View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Hilde Van Boxstael ... (+6)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Lynn Hautekeete
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi
Thomas Vranken
  • Thomas Vranken

Onward Medical A long-awaited present underneath the Christmas tree

Right in line with its YE24 guidance, Onward has successfully obtained FDA approval for its non-invasive ARC-EX device. We see the approval as an important inflection point and expect a phased, relatively de-risked launch given the concentrated patient population and Onward's partnership with Lovell. Although home use is not yet included in the label, we believe this could be addressed in 2025 without additional clinical study requirements. We adjust our TP from € 8.7 to € 10.4 and reiterate a B...

 PRESS RELEASE

ONWARD Medical Receives FDA De Novo Classification and US Market Autho...

ONWARD Medical Receives FDA De Novo Classification and US Market Authorization for World’s First Non-Invasive Spinal Cord Stimulation System for People with Chronic Spinal Cord Injury THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) ARC-EX System is the first and only FDA approved technology shown to improve hand strength and sensation after chronic spinal cord injury ARC-EX System is an FDA Breakthrough Device and 2024 TIME Magazine Best Invention EINDHOVEN, the Netherlands, Dec. 19, 2024 (GLOBE NEWS...

 PRESS RELEASE

ONWARD® Medical reçoit la classification De Novo de la FDA et l'autori...

ONWARD® Medical reçoit la classification De Novo de la FDA et l'autorisation de mise sur le marché américain pour le premier système non invasif au monde de stimulation de la moelle épinière destiné aux personnes atteintes de lésion chronique de la moelle épinière CE COMMUNIQUÉ DE PRESSE CONTIENT DES INFORMATIONS PRIVÉES AU SENS DE L'ARTICLE (7)(1) DU RÈGLEMENT EUROPÉEN SUR LES ABUS DE MARCHÉ (596/2014) Le système ARC-EX® est la première et unique technologie approuvée par la FDA ayant démontré une amélioration de la force et de la sensation des mains après une lésion chronique de la moell...

Montea NV: 1 director

A director at Montea NV bought 460 shares at 62.200EUR and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...

Sharad Kumar S.P
  • Sharad Kumar S.P

Gimv Sale Of Majority Stake In KÖBERL Group

Gimv announced that it has sold its majority stake in KÖBERL Group (facility management and building technology services) to Hungarian company B+N Referencia Zrt. The transaction is anticipated to have a positive impact of approximately €1.0 on Gimv's NAVps and the return on this investment has significantly exceeded Gimv's long-term portfolio return target of 15.0%. This is the third transaction that Gimv has complete post its 1H results. We see this as an indication of the superior quality of ...

Hilde Van Boxstael ... (+5)
  • Hilde Van Boxstael
  • Michiel Declercq
  • Sharad Kumar S.P
  • Wim Hoste
  • Wim Lewi
Guy Sips ... (+12)
  • Guy Sips
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Kristof Samoy
  • Lynn Hautekeete
  • Michiel Declercq
  • Sharad Kumar S.P
  • Thibault Leneeuw
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Hoste
  • Wim Lewi

Dynamic Top Pick List How to start 2025?

On this Friday the 13th we select for you 13 stocks to start 2025 with a bang : ABN Amro, Ackermans & van Haaren, Bekaert, D'Ieteren, EVS, Fagron, Fugro, Gimv, Melexis, Shurgard, Sofina, WDP and Xior However, we maintain a defensive stance in our Benelux selection at the start of 2025.. The long anticipated interest rate cuts by central banks are expected to continue their decline into 2025 (see graph above). However, the Trump election victory in the US hits European stocks even before he tak...

 PRESS RELEASE

ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustaina...

ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability EcoVadis silver medal recognizes Company's environmental and social impact Demonstrates ongoing commitment to integrating sustainable business practices EINDHOVEN, the Netherlands, Dec. 12, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces it has been awarded a silver medal by EcoVadis, the world’s largest p...

Lynn Hautekeete ... (+2)
  • Lynn Hautekeete
  • Wim Lewi

Real Estate Report December 2024

BE-REITS suffer from macro-worries (logistics) and post-Trump knee-jerk reaction. We believe that especially money flows are pushing stocks down as interest rate fears resurfaced in the US. Our top-picks are Shurgard, WDP and Xior. SHUR and WDP have ample headroom on their balance sheet to continue their growth track record. WDP is also very cheap on cash earnings metrics vs. peers. Xior can grow and fix its balance sheet at the same time through contributions in kind.

Guy Sips ... (+4)
  • Guy Sips
  • Kristof Samoy
  • Michiel Declercq
  • Wim Hoste

Local Champions Midcap Conference Book 12.12.2024

This conference book is your guide to our annual Local Champions Mid Cap Conference set to take place on Thursday, 12 December 2024 at our historic building at Grand Place in Brussels. This event offers the possibility to have one-on-one meetings and/or attend small group sessions with the top management and/or IR of the following companies: BARCO | BEKAERT | DECEUNINCK | EKOPAK | EVS | GREENYARD | IBA | JENSEN | ONTEX | RECTICEL | VAN DE VELDE | WHAT'S COOKING? | XFAB

 PRESS RELEASE

NOTICE OF A GENERAL MEETING OF IBA SA

NOTICE OF A GENERAL MEETING OF IBA SA NOTICE OF A GENERAL MEETING OF IBA SA 7 January 2025 at 10 a.m. Dear Shareholder, We have the honour of convening you to a General Meeting of IBA (the "GM") at the Company's [registered office] on 7 January 2025 at 10 a.m. in order to deliberate and vote on the items on the attached agenda. The GM will be held in person at the Company's [registered office]. There will also be an online webcast, accessible by prior registration only, but it will not be possible to vote online. This is a simple webcast. Shareholders are strongly encouraged to v...

 PRESS RELEASE

IBA - Information réglementée

IBA - Information réglementée   IBA SA – Information réglementée Le 6 décembre 2024,18:00 Publication effectuée en vertu de l’article 15 de la loi du 2 mai 2007 relative à la publicité des participations importantes dans des émetteurs dont les actions sont admises à la négociation sur un marché réglementé et portant des dispositions diverses (M.B. 12.VI.2007) (la « Loi ») En vertu de cette disposition : « [...] l'émetteur publie le total du capital, le nombre total de titres conférant le droit de vote et de droits de vote, ainsi que, par catégorie, le nombre de titres conférant le droit...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ageas: Aviva raises Direct Line bid to match Ageas'… final call? IBA: Managers get loan for further 2% of IBA, take 21% of reference shareholder vehicle

Hilde Van Boxstael ... (+7)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Kristof Samoy
  • Lynn Hautekeete
  • Michiel Declercq
  • Sharad Kumar S.P
  • Wim Lewi
 PRESS RELEASE

New generation steps up to continue IBA’s entrepreneurial ownership

New generation steps up to continue IBA’s entrepreneurial ownership Louvain-la-Neuve, Belgium, 5 December 2024 - IBA (Ion Beam Applications SA), the world leader in particle accelerator technology, announces today an initiative aimed at perpetuating the entrepreneurial anchoring of its shareholder base. A new generation of executives will acquire a significant indirect stake in IBA. It is part of a broader strategy to ensure IBA's growth, value creation and sustainability. Company’s success originates from a unique combination between entrepreneurial driving force and reference sharehol...

Sharad Kumar S.P
  • Sharad Kumar S.P

Holdings Report - November 2024 KBCS Holdings Universe Returns -3.6% D...

1M Performance - Absolute: During Nov'24 (1M period), the KBCS Holdings Universe posted a return of -3.6% which was mainly driven by single-asset holdings (-6.9%) while multi-asset holdings posted a slightly less negative return of -2.2%. The 3 top performers during the period were D'Ieteren Group (+5.4%), Gimv (+5.1%) and KBC Ancora (+0.6%) while the 3 worst performers were Compagnie du Bois Sauvage (-10.1%), Heineken Holding (-9.6%) and Quest For Growth (-7.5%). YTD Performance - Relative: O...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Colruyt: 1H24/25F preview – room to beat at EBIT level. Gimv: Major investment in the HVAC industry in France. Kinepolis: US/Canada box office at 94% of pre covid, France attendance recovery at 87%. NSI: Small acquisition in Utrecht

Guy Sips ... (+5)
  • Guy Sips
  • Hilde Van Boxstael
  • Sharad Kumar S.P
  • Wim Hoste
  • Wim Lewi
ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ageas: White Knight option for Direct Line? Exor: Exor CEO John Elkan taking over Stellantis CEO Carlos Tavares' duties. Gimv: Investing in “Made in Germany” lighting. Prosus: 1H25 results. WDP: Sizeable French acquisition

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch